A new breath simulator from Copley Scientific will be on display for the first time at the 18th Congress of the International Society for Aerosols in Medicine (ISAM), 18 – 22 June 2011, Rotterdam, The Netherlands. The new breath simulator allows application of all of the breathing profiles specified in new guidance for nebuliser testing issued in the pharmacopoeia. It is a direct response by Copley Scientific to the changing needs of the inhaled product testing community, which is actively seeking ways to improve the in vivo relevance of in vitro test methods.
The new breath simulator simplifies compliance with the revised pharmacopoeia monograph on the testing of nebulisers (USP chapter 1601 and Ph. Eur 2.9.44) that comes into force in August 2011. In the past, nebuliser testing has been carried out using a standard ‘adult’ breathing profile. The new monograph specifies the application of one of four different profiles – neonate, infant, child or adult, depending on the intended application of the product. The new unit allows the user to specify the volume, frequency and inhalation/exhalation ratio of the applied breathing profile for detailed investigation of the impact of patient physiology on drug delivery.
Robust and well-engineered the new breath simulator has intuitive software that simplifies use. It comes complete with all the connectors and fittings necessary for use with the test apparatus concerned. www.copleyscientific.com
Ends
About Copley Scientific
Copley Scientific is recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company is also active in detergent testing, air sampling and aerosol characterisation.
Copley Scientific’s pharmaceutical product range includes test equipment for: delivered dose uniformity and aerodynamic particle size measurement of metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays; as well as tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories and transdermals.
Copley Scientific has offices in the UK and Switzerland. The company works in partnership with aerosol particle science experts MSP Corporation in North America, and also distributes MSP Corporation’s air sampling and aerosol characterisation products throughout Europe.
Serving the pharmaceutical and associated industries, Copley Scientific offers an extensive range of equipment for research, development and quality control, as well as full validation and aftersales services. This broad range of products is supplied and supported worldwide through a network of specialist distributors. www.copleyscientific.com
